Multicenter Study of Pharmacokinetic-Guided Docetaxel in Breast Cancer Patients Receiving Docetaxel and Cyclophosphamide
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Cancer Female
Interventions: DRUG: Standard of Care: Docetaxel|DRUG: Standard of Care: Cyclophosphamide|OTHER: Function Assessment of Cancer Therapy (FACT) Surveys
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Saladax Biomedical, Inc.